Alibaba launches Qwen3.8, claiming model is second only to Fable 5

1 min read     Updated on 20 Jul 2026, 04:22 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Alibaba launched the Qwen3.8-Max-Preview with 2.4 trillion parameters, available via Token Plan, Qoder, and QoderWork, and plans an open-weight release. The company claims the model is second only to Anthropic's Fable 5, intensifying Chinese AI competition. Analysts maintain a Buy rating with a $192.67 average target, while technical indicators show mixed trends.

powered bylight_fuzz_icon
45672514

*this image is generated using AI for illustrative purposes only.

Alibaba Group Holding Limited launched its Qwen3.8-Max-Preview, a next-generation artificial intelligence model with 2.4 trillion parameters. The company claims the model is comparable to leading frontier AI models, ranking second only to Anthropic's Fable 5. Alibaba stated that Qwen3.8 is continuously evolving and is one of the most powerful models available today.

Availability and Access

The Qwen3.8-Max-Preview is immediately accessible through Alibaba's Token Plan subscription service, as well as its Qoder and QoderWork agentic platforms. The company also announced plans to release Qwen3.8 as an open-weight model, expanding access for developers.

Market Context

The launch intensifies competition among Chinese AI developers, following the release of Moonshot AI's Kimi K3. Alibaba shares gained almost 4% during a recent premarket session as the company pushes to unlock more AI value through expanded developer access and integration with Apple Inc.'s China AI rollout.

Technical Indicators

Alibaba is trading approximately 14.3% above its 20-day simple moving average and 1% above its 50-day average. However, the stock remains 4.6% below its 100-day moving average and 17% below its 200-day average, indicating longer-term pressure. Momentum indicators have improved, with the moving average convergence divergence (MACD) staying above its signal line, suggesting strengthened buying pressure. Resistance is monitored near $134, with support at $118.

Analyst Ratings

The stock maintains a Buy rating with an average price target of $192.67 based on 11 analysts. Recent forecasts include Susquehanna raising its target to $185.00, JP Morgan to $205.00, and Barclays to $195.00.

Analyst Rating Price Target
Susquehanna Positive $185.00
JP Morgan Overweight $205.00
Barclays Overweight $195.00

ETF Exposure

Alibaba holds significant weight in major ETFs, including the Avantis Emerging Markets Equity ETF (1.14%), the Nomura Focused Emerging Markets Equity ETF (2.85%), and the Avantis Responsible Emerging Markets Equity ETF (1.39%).

How will the open-weight release of Qwen3.8 impact the adoption rates among global developers compared to proprietary models?

What specific monetization strategies does Alibaba plan to implement for the Qoder and QoderWork platforms to drive revenue growth?

How will competitors like Moonshot AI respond to Alibaba's claim of superior performance with the Kimi K3 model?

like17
dislike

Schall Law Firm investigates Alibaba over AI extraction claims

2 min read     Updated on 20 Jul 2026, 01:04 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

The Schall Law Firm announced an investigation into Alibaba Group Holding Limited regarding potential securities law violations, triggered by a Reuters report alleging the illicit extraction of Anthropic's Claude AI model capabilities. The investigation focuses on whether Alibaba issued false or misleading statements. This adds to existing legal scrutiny and follows a series of regulatory and financial challenges for the company, including a $600 million non-prosecution agreement with the US Department of Justice.

powered bylight_fuzz_icon
43907907

*this image is generated using AI for illustrative purposes only.

The Schall Law Firm is investigating potential securities claims on behalf of investors of Alibaba Group Holding Limited regarding allegations that the company issued false and misleading statements. This legal scrutiny follows a Reuters report published on June 24, 2026, which detailed accusations by Anthropic that Alibaba illicitly extracted its Claude AI model capabilities. Anthropic characterized the incident as the largest known attack of its kind on the company. The investigation focuses on whether Alibaba failed to disclose pertinent information to investors regarding these security practices.

Anthropic accused Alibaba of obtaining illicit access to its Claude AI model by creating fake accounts, according to a report by the Financial Times on June 24, 2026. Anthropic claimed that operators affiliated with Alibaba and its AI research unit, Qwen, utilized nearly 25,000 fraudulent accounts to generate more than 28.8 million exchanges with its systems between April 22 and June 5, 2026. On this news, Alibaba American Depositary Shares fell 2.7% on June 24, 2026. In response to the security concerns raised by Anthropic, Alibaba Group Holding Ltd will bar its employees from utilizing AI tools developed by Anthropic, effective July 10.

Scale of Reported Interactions

Anthropic provided data comparing the scale of the alleged Alibaba operation to prior incidents involving other entities.

Entity Claude Interactions
DeepSeek More than 150,000
Moonshot AI 3.4 million
MiniMax 13 million
Alibaba / Qwen More than 28.8 million

Regulatory and Financial Developments

The Law Offices of Frank R. Cruz noted that on November 14, 2024, the Financial Times published an article regarding a White House memo claiming Alibaba provides the People’s Liberation Army with capabilities that threaten US security. On this news, Alibaba’s shares fell $6.04, or 3.78%, to close at $153.80 per share on November 14, 2025. Subsequently, on February 13, 2026, the Pentagon added Alibaba to a list of companies aiding the Chinese military before withdrawing the list minutes later, causing the stock to fall $3.00, or 1.9%, to close at $155.73 per share.

On March 19, 2026, Alibaba reported weaker-than-expected financial results, with revenue missing consensus estimates due to weaker transaction activities. The stock fell $9.53, or 7.1%, to close at $124.90 per share. On June 11, 2026, the Beijing branch of the State Administration for Market Regulation summoned Alibaba representatives over alleged false advertising during the annual '618' shopping festival, leading to a 1.4% drop in share price.

On July 1, 2026, the US Department of Justice announced that Alibaba entered a non-prosecution agreement to pay $600 million to resolve allegations that it violated the Federal Food, Drug, and Cosmetic Act by failing to prevent merchants from selling illegal pharmaceuticals through its platforms. On this news, the stock price fell $1.85, or 1.9%, to close at $96.14 per share on July 2, 2026.

How will the internal ban on Anthropic tools impact the development timeline and capabilities of Alibaba's proprietary Qwen AI model?

Could the alleged illicit extraction of Claude AI capabilities trigger broader US export control restrictions on advanced semiconductor sales to Alibaba?

What are the odds that the non-prosecution agreement regarding pharmaceutical sales will lead to stricter, long-term compliance monitoring of Alibaba's merchant platforms?

like17
dislike

More News on Alibaba Group Holding Ltd